So, people are being started, I believe in many cases, on too high of a dose to start with
A major policy change is now emerging for Medicare
Anyone taking it now is doing so through clinical trials or compounding pharmacies, which carries its own set of risks around dosing accuracy and quality control
To put that into context, foods that stimulate GLP-1 in the body provide peak concentrations of about 9.7 and 42 pmol/L (0.032 to 0.139 ng/mL or 32 to 139 pg/mL) 5
Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity
Eli Lilly set Zepbounds direct-to-consumer price at $299$449/month depending on dose